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Choroidal metastasis is the most common intra-ocularmalignancy. Breast and lung cancers represent more than
two thirds of the primary cancer sites.1 Choroidal metastasis
in lung cancer is usually present when multiple other organs
are affected. Although it is not uncommon, with an incidence
rate of 0.7% to 12%,2 there are few published reports because
routine screening is not recommended considering the short
survival and little benefit.3
CASE REPORT
A 60-year-old man was diagnosed as having small cell
lung cancer with multiple bone and pleural metastasis in
September 2004. Although he received two cycles of chemo-
therapy with etoposide (100 mg/m2, day 1–3, every 3 weeks)
and carboplatin (area under the curve 6, day 1, every 3
weeks), the lung mass and disseminated pleural lesions were
aggravated. The patient reported blurred vision and pain in
his right eye. The orbit ultrasonography and funduscopic
examination showed a dome-shaped mass in the right cho-
roid. This solid enhancing mass was also found in brain
magnetic resonance imaging. However, there was no meta-
static brain lesion. Combination chemotherapy with topote-
can (0.75 mg/m2, day 1–5, every 3 weeks) and cisplatin (60
mg/m2, day 1, every 3 weeks) and radiotherapy of 4000 cGy
to the right orbit were administered. Lung and pleural lesions
were partially resolved, and the choroidal mass almost com-
pletely disappeared on funduscopic examination. There were
no further eye symptoms, and the patient died 6 months later
because of disease progression.
Treatment of choroidal metastasis depends on the size
and extent of tumor, the visual status of the affected or
non-affected eye, the stage of lung cancer, and the perfor-
mance of the patient. Radiotherapy may be a reasonable
therapeutic option to improve the quality of remaining life
(Figures 1 and 2).4
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FIGURE 1. (A) A large mass on the
left lower lobe was found on chest
computed tomography. This mass
was proven as a small cell lung can-
cer by bronchoscopic biopsy. (B)
Brain magnetic resonance imaging
showing a solid enhancing mass on
the right eyeball.
FIGURE 2. (A) A dome-shaped
mass in choroids on funduscopy. (B)
A choroidal mass disappeared after
chemotherapy with topotecan and
cisplatin and radiotherapy of 4000
cGy.
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